Cas:1072951-91-7 [3-[(4-chloro-3-methylphenoxy)methyl]phenyl]boronic acid manufacturer & supplier

Chemical Name:[3-[(4-chloro-3-methylphenoxy)methyl]phenyl]boronic acid

CAS.NO:1072951-91-7

Synonyms:[3-[(4-chloro-3-methylphenoxy)methyl]phenyl]boronic acid

Molecular Formula:C₁₄H₁₄BClO₃

Molecular Weight:276.52300

HS Code:2931900090

Physical and Chemical Properties:

Melting point:N/A

Boiling point:N/A

Density:N/A

Index of Refraction:

PSA:49.69000

Exact Mass:276.07200

LogP:1.90720

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:NONH for all modes of transpor

Packing Group:

Contact us for information like [3-[(4-chloro-3-methylphenoxy)methyl]phenyl]boronic acid chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,[3-[(4-chloro-3-methylphenoxy)methyl]phenyl]boronic acid physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,[3-[(4-chloro-3-methylphenoxy)methyl]phenyl]boronic acid Use and application,[3-[(4-chloro-3-methylphenoxy)methyl]phenyl]boronic acid technical grade,usp/ep/jp grade.

Related News: Elliott made its intention for a C-suite overhaul clear in an open letter early July. The activist investor called on GSK to appoint a new board directors with biopharma and consumer health expertise to select the leaders for the two companies. nitroso-psap manufacturers In one of the patients, the viral vector was not present in the cancer cells, and in the other patient it was present at a site (VAMP4) that does not appear to be involved in cancer development. 4-Bromo-2-chlorothiophene suppliers In one of the patients, the viral vector was not present in the cancer cells, and in the other patient it was present at a site (VAMP4) that does not appear to be involved in cancer development. Methyl 4-bromo-3-hydroxy-2-thiophenecarboxylate vendor & factory “We’re going to further invest in research and development to continue to build our pipeline of products, in a more sophisticated way,” he says, holding up a pocket-sized wearable device and a tiny insulin pen to his screen’s camera. “We really believe in this business for the next—we hope—70 years.”,The use of the Spikevax vaccine in children from 12 to 17 years of age will be the same as in people aged 18 and above, EMA said.